211 related articles for article (PubMed ID: 11110712)
1. Keratinocyte growth factor facilitates alloengraftment and ameliorates graft-versus-host disease in mice by a mechanism independent of repair of conditioning-induced tissue injury.
Panoskaltsis-Mortari A; Taylor PA; Rubin JS; Uren A; Welniak LA; Murphy WJ; Farrell CL; Lacey DL; Blazar BR
Blood; 2000 Dec; 96(13):4350-6. PubMed ID: 11110712
[TBL] [Abstract][Full Text] [Related]
2. Keratinocyte growth factor administered before conditioning ameliorates graft-versus-host disease after allogeneic bone marrow transplantation in mice.
Panoskaltsis-Mortari A; Lacey DL; Vallera DA; Blazar BR
Blood; 1998 Nov; 92(10):3960-7. PubMed ID: 9808590
[TBL] [Abstract][Full Text] [Related]
3. Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease.
Krijanovski OI; Hill GR; Cooke KR; Teshima T; Crawford JM; Brinson YS; Ferrara JL
Blood; 1999 Jul; 94(2):825-31. PubMed ID: 10397751
[TBL] [Abstract][Full Text] [Related]
4. KGF pretreatment decreases B7 and granzyme B expression and hastens repair in lungs of mice after allogeneic BMT.
Panoskaltsis-Mortari A; Ingbar DH; Jung P; Haddad IY; Bitterman PB; Wangensteen OD; Farrell CL; Lacey DL; Blazar BR
Am J Physiol Lung Cell Mol Physiol; 2000 May; 278(5):L988-99. PubMed ID: 10781430
[TBL] [Abstract][Full Text] [Related]
5. Engraftment of severe combined immune deficient mice receiving allogeneic bone marrow via In utero or postnatal transfer.
Blazar BR; Taylor PA; McElmurry R; Tian L; Panoskaltsis-Mortari A; Lam S; Lees C; Waldschmidt T; Vallera DA
Blood; 1998 Nov; 92(10):3949-59. PubMed ID: 9808589
[TBL] [Abstract][Full Text] [Related]
6. [Significance of donors treatment with combination of recombinant human interleukin-11 and recombinant human granulocyte-colony stimulating factor in reduction of incidence of lethal grafts versus host disease after allogeneic bone marrow transplantation].
Zhao J; Zhao XY; Huang XJ
Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(35):2497-502. PubMed ID: 16321278
[TBL] [Abstract][Full Text] [Related]
7. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
Li JM; Gorechlad J; Larsen CP; Waller EK
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
[TBL] [Abstract][Full Text] [Related]
8. Cyclophosphamide prevents systemic keratinocyte growth factor-induced up-regulation of surfactant protein A after allogeneic transplant in mice.
Yang S; Panoskaltsis-Mortari A; Ingbar DH; Matalon S; Zhu S; Resnik ER; Farrell CL; Lacey DL; Blazar BR; Haddad IY
Am J Respir Crit Care Med; 2000 Nov; 162(5):1884-90. PubMed ID: 11069830
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-10 administration decreases survival in murine recipients of major histocompatibility complex disparate donor bone marrow grafts.
Blazar BR; Taylor PA; Smith S; Vallera DA
Blood; 1995 Feb; 85(3):842-51. PubMed ID: 7833486
[TBL] [Abstract][Full Text] [Related]
10. Donor CD4-enriched cells of Th2 cytokine phenotype regulate graft-versus-host disease without impairing allogeneic engraftment in sublethally irradiated mice.
Fowler DH; Kurasawa K; Smith R; Eckhaus MA; Gress RE
Blood; 1994 Nov; 84(10):3540-9. PubMed ID: 7949109
[TBL] [Abstract][Full Text] [Related]
11. Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation.
Min D; Taylor PA; Panoskaltsis-Mortari A; Chung B; Danilenko DM; Farrell C; Lacey DL; Blazar BR; Weinberg KI
Blood; 2002 Jun; 99(12):4592-600. PubMed ID: 12036893
[TBL] [Abstract][Full Text] [Related]
12. Delayed infusion of immunocompetent donor cells after bone marrow transplantation breaks graft-host tolerance allows for persistent antileukemic reactivity without severe graft-versus-host disease.
Johnson BD; Truitt RL
Blood; 1995 Jun; 85(11):3302-12. PubMed ID: 7756664
[TBL] [Abstract][Full Text] [Related]
13. Effect of recombinant human macrophage colony-stimulating factor in irradiated murine recipients of T-cell-depleted allogeneic or non-depleted syngeneic bone marrow transplants.
Blazar BR; Aukerman SL; Vallera DA
Blood; 1992 Mar; 79(6):1636-42. PubMed ID: 1547353
[TBL] [Abstract][Full Text] [Related]
14. Delaying transplantation after total body irradiation is a simple and effective way to reduce acute graft-versus-host disease mortality after major H2 incompatible transplantation.
Xun CQ; Tsuchida M; Thompson JS
Transplantation; 1997 Jul; 64(2):297-302. PubMed ID: 9256191
[TBL] [Abstract][Full Text] [Related]
15. Regulation of glutathione redox status in lung and liver by conditioning regimens and keratinocyte growth factor in murine allogeneic bone marrow transplantation.
Ziegler TR; Panoskaltsus-Mortari A; Gu LH; Jonas CR; Farrell CL; Lacey DL; Jones DP; Blazar BR
Transplantation; 2001 Oct; 72(8):1354-62. PubMed ID: 11685103
[TBL] [Abstract][Full Text] [Related]
16. Polarized type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host disease.
Krenger W; Snyder KM; Byon JC; Falzarano G; Ferrara JL
J Immunol; 1995 Jul; 155(2):585-93. PubMed ID: 7608537
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of in vivo elimination of suicide gene-expressing T cells affects engraftment, graft-versus-host disease, and graft-versus-leukemia after allogeneic bone marrow transplantation.
Rettig MP; Ritchey JK; Prior JL; Haug JS; Piwnica-Worms D; DiPersio JF
J Immunol; 2004 Sep; 173(6):3620-30. PubMed ID: 15356106
[TBL] [Abstract][Full Text] [Related]
18. Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer T cells.
Lan F; Zeng D; Higuchi M; Higgins JP; Strober S
Biol Blood Marrow Transplant; 2003 Jun; 9(6):355-63. PubMed ID: 12813443
[TBL] [Abstract][Full Text] [Related]
19. Repifermin (keratinocyte growth factor-2) reduces the severity of graft-versus-host disease while preserving a graft-versus-leukemia effect.
Clouthier SG; Cooke KR; Teshima T; Lowler KP; Liu C; Connolly K; Ferrara JL
Biol Blood Marrow Transplant; 2003 Sep; 9(9):592-603. PubMed ID: 14506661
[TBL] [Abstract][Full Text] [Related]
20. Keratinocyte growth factor enhanced immune reconstitution in murine allogeneic umbilical cord blood cell transplant.
Wang Y; Chen G; Qiao S; Ma X; Tang X; Sun A; Wu D
Leuk Lymphoma; 2011 Aug; 52(8):1556-66. PubMed ID: 21649545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
